Kim SJ - Search Results

1

CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation.

Fang Z, Jung KH, Yan HH, Kim SJ, Son MK, Rumman M, Lee H, Kim KW, Yoo HD, Hong SS. Fang Z, et al. Among authors: kim sj, kim kw. Int J Oncol. 2015 Jul;47(1):253-61. doi: 10.3892/ijo.2015.2994. Epub 2015 May 11. Int J Oncol. 2015. PMID: 25963192

2

HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.

Yun SM, Jung KH, Kim SJ, Fang Z, Son MK, Yan HH, Lee H, Kim J, Shin S, Hong S, Hong SS. Yun SM, et al. Among authors: kim sj, kim j. Cancer Lett. 2014 Jun 28;348(1-2):50-60. doi: 10.1016/j.canlet.2014.03.012. Epub 2014 Mar 18. Cancer Lett. 2014. PMID: 24657654

3

HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation.

Kim SJ, Jung KH, Yan HH, Son MK, Fang Z, Ryu YL, Lee H, Lim JH, Suh JK, Kim J, Lee S, Hong S, Hong SS. Kim SJ, et al. Among authors: kim j. Oncotarget. 2015 Jan 30;6(3):1507-18. doi: 10.18632/oncotarget.2837. Oncotarget. 2015. PMID: 25483100 Free PMC article.

4

HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.

Rumman M, Jung KH, Fang Z, Yan HH, Son MK, Kim SJ, Kim J, Park JH, Lim JH, Hong S, Hong SS. Rumman M, et al. Among authors: kim sj, kim j. Oncotarget. 2016 Nov 22;7(47):78029-78047. doi: 10.18632/oncotarget.12871. Oncotarget. 2016. PMID: 27793006 Free PMC article.

5

A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells.

Lee H, Kim SJ, Jung KH, Son MK, Yan HH, Hong S, Hong SS. Lee H, et al. Among authors: kim sj. Oncol Rep. 2013 Aug;30(2):863-9. doi: 10.3892/or.2013.2499. Epub 2013 May 27. Oncol Rep. 2013. PMID: 23708425

6

SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells.

Son MK, Jung KH, Lee HS, Lee H, Kim SJ, Yan HH, Ryu YL, Hong SS. Son MK, et al. Among authors: kim sj. Oncol Rep. 2013 Aug;30(2):801-8. doi: 10.3892/or.2013.2517. Epub 2013 Jun 4. Oncol Rep. 2013. PMID: 23733203

7

Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells.

Ryu YL, Jung KH, Son MK, Yan HH, Kim SJ, Shin S, Hong S, Hong SS. Ryu YL, et al. Among authors: kim sj. Cancer Lett. 2014 Oct 10;353(1):68-77. doi: 10.1016/j.canlet.2014.07.001. Epub 2014 Jul 10. Cancer Lett. 2014. PMID: 25016056

8

Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer.

Yan HH, Jung KH, Son MK, Fang Z, Kim SJ, Ryu YL, Kim J, Kim MH, Hong SS. Yan HH, et al. Among authors: kim sj, kim j, kim mh. Oncotarget. 2014 Oct 15;5(19):9150-68. doi: 10.18632/oncotarget.2363. Oncotarget. 2014. PMID: 25193856 Free PMC article.

9

Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.

Kim SJ, Jung KH, Son MK, Park JH, Yan HH, Fang Z, Kang YW, Han B, Lim JH, Hong SS. Kim SJ, et al. Cancer Lett. 2017 Sep 10;403:339-353. doi: 10.1016/j.canlet.2017.06.035. Epub 2017 Jul 6. Cancer Lett. 2017. PMID: 28688971

10

Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer.

Park JH, Jung KH, Kim SJ, Fang Z, Yan HH, Son MK, Kim J, Kang YW, Lee JE, Han B, Lim JH, Hong SS. Park JH, et al. Among authors: kim sj, kim j. Oncotarget. 2017 Dec 1;8(68):112893-112906. doi: 10.18632/oncotarget.22850. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348875 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,266 results

Search Page

Filters